Verve Therapeutics
Kim Milliken is an experienced professional in the field of regulatory affairs and quality control with a strong background in microbiology. With a degree in Microbiology from the University of New Hampshire, Kim has held various roles at companies such as Verve Therapeutics, Takeda, Lonza Biologics, and Biogen. Kim's expertise ranges from QC Analyst to Executive Director Regulatory CMC, showcasing a well-rounded career in the pharmaceutical industry.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.